Nanoparticle-enhanced proton beam immunoradiotherapy drives immune activation and durable tumor rejection-Reference-Cited by-同舟云学术

Nanoparticle-enhanced proton beam immunoradiotherapy drives immune activation and durable tumor rejection

Published:2023-06-22 Issue:12 Volume:8 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Hu Yun,Paris Sébastien^ORCID,Sahoo Narayan^ORCID,Bertolet Genevieve^ORCID,Wang Qi,Wang Qianxia,Barsoumian Hampartsoum B.,Da Silva Jordan,Huang Ailing,Doss Denaha J.,Pollock David P.,Hsu Ethan,Selene Nanez,Leyton Claudia S. Kettlun,Voss Tiffany A.,Masrorpour Fatemeh,Ganjoo Shonik,Leuschner Carola,Pietz Jordan T.,Puebla-Osorio Nahum^ORCID,Gandhi Saumil,Nguyen Quynh-Nhu,Wang Jing,Cortez Maria Angelica,Welsh James W.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/167749/files/pdf

Reference72 articles.

1. Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy

2. Radioimmunotherapy for the treatment of head and neck cancer

3. Radiation therapy to enhance tumor immunotherapy: a novel application for an established modality

4. Radiation Therapy Enhanced by NBTXR3 Nanoparticles Overcomes Anti-PD1 Resistance and Evokes Abscopal Effects

5. A radioenhancing nanoparticle mediated immunoradiation improves survival and generates long-term antitumor immune memory in an anti-PD1-resistant murine lung cancer model

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer;Journal of Nanobiotechnology;2024-07-20

2. Application of nano-radiosensitizers in non-small cell lung cancer;Frontiers in Oncology;2024-04-05

3. The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific Perspectives;International Journal of Radiation Oncology*Biology*Physics;2024-04

4. Inhibition of MER proto-oncogene tyrosine kinase by an antisense oligonucleotide enhances treatment efficacy of immunoradiotherapy;Journal of Experimental & Clinical Cancer Research;2024-03-06

5. Cutting-Edge Therapies for Lung Cancer;Cells;2024-03-01